RQ 04
Alternative Names: RQ-04Latest Information Update: 24 Nov 2023
At a glance
- Originator Red Queen Therapeutics
- Class Antivirals; Peptides
- Mechanism of Action Virus internalisation inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Research Ebola virus infections
Most Recent Events
- 12 Oct 2023 Early research in Ebola virus infections in USA (Unspecified) (Red Queen Therapeutics pipeline, October 2023)
- 10 Oct 2023 Red Queen Therapeutics has patent protection for Red Queen hypothesis technology (Red Queen Therapeutics website, October 2023)